Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 17 of 37, showing 5 Applications out of 183 total, starting on record 81, ending on 85

# Protocol No Study Title Investigator(s) & Site(s)

81.

ECCT/19/04/05   PHOENIx MDR-TB
    A5300B/I2003B/PHOENIx "Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients"   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
View

82.

ECCT/14/09/04  
    Assessment of Safety and Efficacy of Brozedex Syrup in the Treatment of Productive Cough. Phase III, Randomized, Double Blind, Placebo-Controlled, Parallel Group and Multi-Site Study Conducted In Nairobi in three sites    
Principal Investigator(s)
1. Hudson Aubrey Lodenyo
Site(s) in Kenya
1. Rhodes Clinic/Ngaira Health Centre (Nairobi City county)
2. Mbagathi District Hospital (Nairobi City county)
3. Mama Lucy Hospital (Nairobi City county)
 
View

83.

ECCT/17/08/02   IMPROVE (Improving PRegnancy Outcomes with intermittent PReVEntive treatment in Africa)
    IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in pregnancy in high sulphadoxine-pyrimethamine resistance areas in Kenya, Malawi and Tanzania: an international multi-centre 3-arm placebo-controlled trial   
Principal Investigator(s)
1. Simon Kariuki
Site(s) in Kenya
1. Migori County Referral Hospital (Migori county)
2. Homa Bay County Referral Hospital (Homa Bay county)
3. Rongo Sub-County Hospital (Migori county)
4. Ahero Sub-County Hospital (Kisumu county)
5. Rabuor Sub-County Hospital (Kisumu county)
 
View

84.

ECCT/14/06/01   ACTG -5279
    Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Dr. Kevin N/A Cain
Site(s) in Kenya
1. KEMRI/WRP CRS (Kericho county)
2. Moi University Clinical Research Center CRS ()12601 (Uasin Gishu county)
 
View

85.

ECCT/12/09/03   REALITY Trial
    Reduction of EArly mortaLITY in HIV-infected adults and children starting antiretroviral therapy   
Principal Investigator(s)
1. DR ANTHONY OLIWA ETYANG
Site(s) in Kenya
1. KEMRI Wellcome Trust Research Programme (Kilifi county)
2. Moi University School of Medicine, Academic Model for the Prevention and Treatment of HIV/AIDS (AMPATH) Centre at Moi Teaching Referral Hospital (MTRH) (Uasin Gishu county)
 
View